SM
Publications
71
Views
19,155
Downloads
5,178
Supervised works
0
Items per page
1 - 71 of 71
Title Published in Access level OA Policy Year Views Downloads
Utility of the 2024 best practice recommendations from the EBMT Cellular Therapy and Immunobiology Working Party for use of donor lymphocyte infusions after allogeneic hematopoietic stem cell transplantationBone marrow transplantation
accessLevelRestricted
2024 30 0
Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation : a case reportFrontiers in immunology
accessLevelPublic
2024 31 19
Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission : results of a randomized phase III studyHaematologica
accessLevelPublic
2024 40 16
Severe anaphylaxis after chimeric antigen receptor T-cell injection : a case reportEJHaem
accessLevelPublic
2024 28 29
Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021Hematological oncology
accessLevelRestricted
2024 65 0
Impact of intermittent versus continuous infusions on central line-associated bloodstream infection risk in haemato-oncology patients : a quasi-experimental studyJournal of hospital infection
accessLevelPublic
2024 31 25
Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugsSwiss medical weekly
accessLevelPublic
2024 38 8
Deuxième allogreffe (mise à jour). Recommandations de la Société francophone de greffe de moelle osseuse et de thérapie cellulaire (SFGM-TC)Bulletin du cancer
accessLevelRestricted
2024 24 0
Pre-engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxisTransplant infectious disease
accessLevelPublic
2024 33 24
Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation : a longitudinal retrospective multicenter studyBone marrow transplantation
accessLevelPublic
2024 45 13
NK and T cell repertoire is established early after allogeneic HSCT and is profoundly imprinted by CMV reactivationBlood advances
accessLevelPublic
2024 56 34
Routine infectious disease consultation prior to an allogeneic hematopoietic cell transplantOpen forum infectious diseases
accessLevelPublic
2023 41 37
Revisiting cytomegalovirus serology in allogeneic hematopoietic cell transplant recipientsClinical infectious diseases
accessLevelPublic
2023 76 40
Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for FLT3-ITD AML reveals high rates of toxicity-related treatment interruptionFrontiers in oncology
accessLevelPublic
2023 38 18
Allogeneic hematopoietic stem cell transplantation in non-Hodgkin lymphoma in Switzerland, 30 years of experience : Sooner is betterEJHaem
accessLevelPublic
2023 49 20
CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant RecipientsOpen forum infectious diseases
accessLevelPublic
2023 82 22
CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantationLeukemia & lymphoma
accessLevelPublic
2023 48 20
Graft versus host disease (GvHD) prevention in allogeneic hematopoietic stem cell transplantation: T cell depletion strategies to reduce GvHD risk while preserving graft versus tumor (GvT) effect
accessLevelRestricted
2023 79 4
Longitudinal Detection of Twenty DNA and RNA Viruses in Allogeneic Hematopoietic Stem Cell Transplant Recipients PlasmaViruses
accessLevelPublic
2023 123 68
Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant RecipientsAntimicrobial agents and chemotherapy
accessLevelPublic
2023 63 135
Hepatitis E Virus Infection Epidemiology in Recipients of Allogeneic Hematopoietic Cell TransplantOpen forum infectious diseases
accessLevelPublic
2023 41 34
Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma in Switzerland, 20 years of experience : 2001-2020EJHaem
accessLevelPublic
2023 69 14
Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress?Open forum infectious diseases
accessLevelPublic
2022 242 134
Human pegivirus-1 replication influences NK cell reconstitution after allogeneic haematopoietic stem cell transplantationFrontiers in immunology
accessLevelPublic
2022 77 35
Atypical pulmonary phaeohyphomycosis due to Aureobasidium spp. - case report and brief literature reviewSwiss medical weekly
accessLevelPublic
2022 150 34
Rhinovirus infections among hematopoietic stem cell transplant recipients: a pre-transplant dilemma?Viruses
accessLevelPublic
2022 164 72
Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant RecipientsAntimicrobial agents and chemotherapy
accessLevelPublic
2022 65 86
Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infectionsMycoses
accessLevelPublic
2022 250 117
Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMTBone marrow transplantation
accessLevelPublic
2022 217 78
Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation : A Retrospective StudyTransplantation and cellular therapy
accessLevelPublic
2022 105 53
T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipientsAnnals of oncology
accessLevelPublic
2022 153 45
When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?Mycoses
accessLevelPublic
2022 71 32
Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantationBlood advances
accessLevelPublic
2021 264 85
The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graftBone marrow transplantation
accessLevelRestricted
2021 285 0
Unmasking viral sequences by metagenomic next-generation sequencing in adult human blood samples during steroid-refractory/dependent graft-versus-host diseaseMicrobiome
accessLevelPublic
2021 338 213
Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trialAnnals of hematology
accessLevelPublic
2021 237 104
Letermovir Primary Prophylaxis in High-Risk Hematopoietic Cell Transplant Recipients: A Matched Cohort StudyVaccines
accessLevelPublic
2021 170 160
Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipientsBone marrow transplantation
accessLevelRestricted
2021 243 2
Predictors of breakthrough clinically significant cytomegalovirus infection during letermovir prophylaxis in high-risk hematopoietic cell transplant recipientsImmunity, inflammation and disease
accessLevelPublic
2021 290 85
Clinical considerations of isavuconazole administration in high-risk hematological patients: a single-center 5-year experienceMycopathologia
accessLevelPublic
2021 208 110
Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipientsMedical mycology
accessLevelRestricted
2021 286 1
Clinical and Pharmacological Considerations for Concomitant Administration of Posaconazole and Isavuconazole with LetermovirAntimicrobial agents and chemotherapy
accessLevelPublic
2021 203 292
Real-life considerations on antifungal treatment combinations for the management of invasive mold infections after allogeneic cell transplantationJournal of Fungi
accessLevelPublic
2021 154 100
Successful treatment of central nervous system lymphoproliferative disorder in a kidney-pancreas and stem cell transplanted patient using intrathecal rituximabBMJ case reports
accessLevelRestricted
2021 208 1
Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantationLeukemia
accessLevelPublic
2020 357 247
Torque Teno Virus as a potential biomarker for complications and survival after allogeneic hematopoietic stem cell transplantationFrontiers in Immunology
accessLevelPublic
2020 497 141
Intracellular Pathogen in the Cerebrospinal Fluid of an Allogeneic Hematopoietic Cell Transplant Recipient With Graft-Versus-Host Disease and Brain LesionsClinical infectious diseases
accessLevelRestricted
2020 235 0
Evaluation of Disease Risk Comorbidity Index after Allogeneic Stem Cell Transplantation in a Cohort with Patients Undergoing Transplantation with In Vitro Partially T Cell Depleted GraftsBiology of Blood and Marrow Transplantation
accessLevelPublic
2020 275 194
Optimal treatment duration of pseudomonas aeruginosa infections in allogeneic hematopoietic cell transplant recipientsOpen Forum Infectious Diseases
accessLevelPublic
2020 427 112
Microbiologically documented infections after adult allogeneic hematopoietic cell transplantation: A 5-year analysis within the Swiss Transplant Cohort studyTransplant Infectious Disease
accessLevelRestricted
2020 357 2
Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell TransplantationFrontiers in Immunology
accessLevelPublic
2019 315 119
Allograft and patient survival after sequential HSCT and kidney transplantation from the same donor-A multicenter analysisAmerican journal of transplantation
accessLevelPublic
2019 111 42
Compartmentalization of a Multidrug-Resistant Cytomegalovirus UL54 Mutant in a Stem Cell Transplant Recipient with EncephalitisThe Journal of Infectious Diseases
accessLevelRestricted
2019 238 0
Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantationLeukemia and Lymphoma
accessLevelRestricted
2018 508 2
Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016Swiss Medical Weekly
accessLevelPublic
2018 426 182
Impact of T-cell depletion on outcome of patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndromeBone Marrow Transplantation
accessLevelRestricted
2018 402 0
Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective studyBMC Infectious Diseases
accessLevelPublic
2018 494 205
Human pegivirus persistence in the human blood virome after allogeneic haematopoietic stem cell transplantationClinical Microbiology and Infection
accessLevelPublic
2018 1,335 352
Torque Teno Virus Load and Acute Rejection after Orthotopic Liver TransplantationTransplantation
accessLevelRestricted
2017 768 0
FLT3-ITD mutations do not impact the outcome of patients allografted with partial T-cell depleted grafts for AML with normal cytogenetics in first complete remissionHematological oncology
accessLevelRestricted
2017 519 3
Outcome of hematopoietic stem cell transplantation is similar for patients with a partial in vitro T-cell-depleted graft compared with a non-T-cell-depleted graft when stratified by the refined disease risk indexBone marrow transplantation
accessLevelRestricted
2016 609 2
Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplantsBone marrow transplantation
accessLevelRestricted
2016 626 4
Immunological Basis of Bone Marrow Failure after Allogeneic Hematopoietic Stem Cell TransplantationFrontiers in Immunology
accessLevelPublic
2016 471 228
Torque teno virus in patients undergoing allogeneic hematopoietic stem cell transplantation for hematological malignanciesBone marrow transplantation
accessLevelRestricted
2016 467 2
Transplantation de cellules souches hématopoïétiques périphériques partiellement déplétées en lymphocytes T chez les patients avec anémie aplastique sévère : excellents résultats et incidence élevée de chimérisme mixte
accessLevelPublic
2016 759 525
Complete and sustained remission of spondyloarthritis after allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromeJoint bone spine
accessLevelRestricted
2015 567 2
Very Long Term Stability of Mixed Chimerism after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematologic MalignanciesBone marrow research
accessLevelPublic
2015 546 94
In-Hospital Transfer Is a Risk Factor for Invasive Filamentous Fungal Infection among Hospitalized Patients with Hematological Malignancies: A Matched Case-Control StudyInfection control and hospital epidemiology
accessLevelRestricted
2015 585 1
NK Cell Functional Impairment after Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Reduced Levels of T-bet and EomesoderminThe Journal of immunology
accessLevelRestricted
2015 530 3
Comparing Two Types of Rabbit ATG prior to Reduced Intensity Conditioning Allogeneic Hematopoietic SCT for Hematologic MalignanciesBone marrow research
accessLevelPublic
2015 655 296
Validation of the disease risk index for outcome of patients undergoing allogeneic hematopoietic stem cell transplantation after T cell depletionBiology of blood and marrow transplantation
accessLevelRestricted
2014 566 1
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack